Gynaecology oncology is usually associated with this.
Gynaecology tumours are those occurring in the female reproductive system, including ovarian, cervical, membrane, genital and vaginal cancers. The mechanism for the development of gynaecological tumours is complex and is usually associated with a number of factors, including the following, which may be associated with gynaecological tumour diseases:
I. Genetic factors
1. Genetic orientation: Some gynaecological neoplasms have a genetic orientation, such as family breast and ovarian cancer syndrome (bRCA1 and BRCA2 genetic mutation), Lynch syndrome (as related to colon and uterine membrane cancer).
2. Family history: Women with gynaecology tumours are at higher risk, especially those with immediate family (mother, sister) ovarian or breast cancer.
II. Hormonal factors
Estrogen: Long-term exposure to high-level estrogen environments, such as ovulation, infertility, late menopause, may increase the risk of uterine cancer.
2. Pregnant hormones: Females with low or non-ovovable levels of pregnancy hormones have long-term estrogen irritation of the uterine endometrium, which can lead to increased intrauterine membrane growth and increase the risk of uterine cancer.
3. Contraceptives and hormone substitution therapy: the long-term use of estrogen-containing contraceptives and hormone substitution therapy may affect hormone levels and are related to the occurrence of certain gynaecological tumours.
Lifestyle factors
1. Smoking: smoking is associated with increased risk of cervical, ovarian and genital cancer.
Diet: High fat, low-fibrous dietary habits are associated with increased risk of uterine membrane cancer.
3. Weight: Obesity is an independent risk factor for uterine cancer and is related to the increased risk of ovarian cancer.
4. Fertility history: Late, under- and infertility can increase the risk of ovarian and uterine cancer. Multiple pregnancies and early childbearing may reduce these risks.
IV. STIS
1. Human papillomavirus (HPV): HPV infection is a major risk factor for cervical and vaginal cancer, especially HPV16 and HPV18.
2. Sandeye chlamydia and other sexually transmitted infections: Some studies have shown that trachoma infection may be associated with increased risk of cervical cancer.
V. Environmental factors
Chemical substances: Long-term exposure to certain chemical substances, such as asbestos, benzene and radioactive substances, may increase the risk of ovarian cancer.
2. Occupational exposure: Certain occupations, such as nurses, pilots and farmers, may increase the risk of gynaecological tumours due to occupational exposure.
VI. Chronic diseases
Diabetes: Anomalous hormonal levels in diabetes patients may be associated with increased risk of uterine membrane cancer.
Chronic inflammation: Chronic pelvic inflammation may be associated with increased risk of ovarian cancer.
VII. Age
With age, the risk of tumours in gynaecology increases, especially among women after menopause.
VIII. Immunisation status
Inadequate functioning of the immune system, such as HIV infection and immunosuppressive treatment following organ transplants, may increase the risk of certain gynaecological tumours.
IX. OTHER ELEMENTS
1. Fertility control methods: IUDs may reduce the risk of uterine membrane cancer.
Fertility treatment: Certain fertility treatments, such as in vitro fertilization (IVF), may be associated with increased risk of ovarian cancer.
3. Personal history of diseases, such as uterine membrane amphibolism, multi-cystic ovary syndrome, may be related to the increased risk of certain gynaecological tumours.
Summary
The occurrence of gynaecological tumours is a multi-factor and multi-step process involving a variety of factors, including genetic, hormone, lifestyle, infection and the environment. Understanding these risk factors helps to raise awareness about the prevention of gynaecological tumours and to reduce the risk of morbidity through measures such as healthy lifestyles, periodic medical examinations and vaccinations (e.g. HPV vaccine). For women with high-risk factors, individualized monitoring and prevention strategies should be developed in communication with medical professionals.
